Darifenacin Hydrobromide | Health Canada | Drug Product Database | DPD | PharmaCompass.com

Please Wait

Applying Filters...

Grow Your Pharma Business Digitally

Find Suppliers : API/FDF
- Search Our Integrated Database
Services
Excipients
Drugs in Dev.
News
Blog
Market Place
Login

Darifenacin Hydrobromide
Canada

Seqens is an integrated global leader in pharmaceutical solutions & specialty ingredients & provides custom-made solutions.

Contact Supplier

AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

Contact Supplier

ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

Contact Supplier

xyz-pharma-m-2024-10-07

Contact Supplier

Darifenacin Hydrobromide

ACCESS ALL DATA, CHEMISTRY

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

27 API Suppliers, 15 USDMF, 9 EU WC, 7 NDC API, 15 Listed Suppliers, $ API Reference Price

27 API Suppliers
15 USDMF
9 EU WC
7 NDC API
15 Listed Suppliers
$ API Reference Price

INTERMEDIATES

8 API Suppliers

8 API Suppliers

FINISHED DOSAGE FORMULATIONS

55 FDF Dossiers, 20 FDA Orange Book, 14 Europe, 6 Canada, 5 South Africa, 10 Listed Dossiers

55 FDF Dossiers
20 FDA Orange Book
14 Europe
6 Canada
5 South Africa
10 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

TABLET, EXTENDED RELEASE;ORAL - EQ 15MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
TABLET, EXTENDED RELEASE;ORAL - EQ 7.5MG BASE **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 Seqens, 3 DKSH, 3 Boai NKY Pharmaceuticals Ltd, 8 Gangwal Healthcare, 5 Nanjing Well Pharmaceutical, 1 ACG Worldwide, 3 Actylis, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 Avesta Pharma, 9 BASF, 3 Clariant, 10 Corel Pharma Chem, 4 DFE Pharma, 1 Finar, 8 Gangwal Chemicals, 7 Ideal Cures Pvt Ltd, 31 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 10 Microlex e.U, 2 Nomisma Healthcare, 2 Novo Excipients, 1 Pharmatrans-Sanaq, 2 Pluviaendo, 2 Prachin Chemical, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 9 Roquette, 6 Seppic, 4 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 1 Shanghai Welltone Material Technology Co., Ltd, 10 Sigachi Industries, 2 The Dow Chemical Company, 1 Ulanqab Kema New Material, 2 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

50 Coating Systems & Additives, 50 Fillers, Diluents & Binders, 28 Controlled & Modified Release, 20 Direct Compression, 18 Thickeners and Stabilizers, 17 Lubricants & Glidants, 14 Topical, 13 Co-Processed Excipients, 11 Film Formers & Plasticizers, 11 Granulation, 8 Solubilizers, 7 Parenteral, 7 Disintegrants & Superdisintegrants, 6 API Stability Enhancers, 5 Empty Capsules, 5 Emulsifying Agents, 4 Vegetarian Capsules, 4 Taste Masking, 4 Coloring Agents, 3 Chewable & Orodispersible Aids, 3 Rheology Modifiers, 2 Surfactant & Foaming Agents

50 Coating Systems & Additives
50 Fillers, Diluents & Binders
28 Controlled & Modified Release
20 Direct Compression
18 Thickeners and Stabilizers
17 Lubricants & Glidants
14 Topical
13 Co-Processed Excipients
11 Film Formers & Plasticizers
11 Granulation
8 Solubilizers
7 Parenteral
7 Disintegrants & Superdisintegrants
6 API Stability Enhancers
5 Empty Capsules
5 Emulsifying Agents
4 Vegetarian Capsules
4 Taste Masking
4 Coloring Agents
3 Chewable & Orodispersible Aids
3 Rheology Modifiers
2 Surfactant & Foaming Agents

DIGITAL CONTENT

12 NEWS #PharmaBuzz

12 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

10 Finished Drug Prices, 2 Annual Reports

10 Finished Drug Prices
2 Annual Reports

MARKET PLACE

2 APIs, 4 FDF Dossiers

2 APIs
4 FDF Dossiers

PATENTS & EXCLUSIVITIES

8 Health Canada Patents

8 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 USP, 4 Others

3 USP
4 Others

ANALYTICAL

1 BioAnalytical Methods

1 BioAnalytical Methods

$ API Ref.Price (USD/KG) : 4,535 Xls

Filters

Reset all filters

Filters

FILTER :

filter Applicant Reset all filters

6 All

01 2APOTEX INC

02 2JAMP PHARMA CORPORATION

03 2SEARCHLIGHT PHARMA INC

filter Active Ingredients Reset all filters

6 All

01 6DARIFENACIN (DARIFENACIN HYDROBROMIDE)

filter Dosage Form Reset all filters

6 All

01 6TABLET (EXTENDED-RELEASE)

filter Brand Name Reset all filters

6 All

01 2APO-DARIFENACIN

02 2ENABLEX

03 2JAMP DARIFENACIN

List of Suppliers

Product Main Page

01

APOTEX INC

2024 ACI Convention

Not Confirmed

APOTEX INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : APO-DARIFENACIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 15MG

Packaging : 30/100

Approval Date :

Application Number : 2452529

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

02

APOTEX INC

2024 ACI Convention

Not Confirmed

APOTEX INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : APO-DARIFENACIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 7.5MG

Packaging : 30/100

Approval Date :

Application Number : 2452510

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Corporate PDF

03

JAMP PHARMA CORPORATION

2024 ACI Convention

Not Confirmed

JAMP PHARMA CORPORATION

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : JAMP DARIFENACIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 7.5MG

Packaging :

Approval Date :

Application Number : 2491869

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

04

JAMP PHARMA CORPORATION

2024 ACI Convention

Not Confirmed

JAMP PHARMA CORPORATION

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : JAMP DARIFENACIN

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 15MG

Packaging :

Approval Date :

Application Number : 2491877

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

05

SEARCHLIGHT PHARMA INC

2024 ACI Convention

Not Confirmed

SEARCHLIGHT PHARMA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : ENABLEX

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 15MG

Packaging : Jul-28

Approval Date :

Application Number : 2273225

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

06

SEARCHLIGHT PHARMA INC

2024 ACI Convention

Not Confirmed

SEARCHLIGHT PHARMA INC

2024 ACI Convention

Not Confirmed

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass. Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.

Post an Enquiry

Post an Enquiry

Digital Content

Regulatory Info : Prescription

Registration Country : Canada

DARIFENACIN (DARIFENACIN HYDROBROMIDE)

Brand Name : ENABLEX

Dosage Form : TABLET (EXTENDED-RELEASE)

Dosage Strength : 7.5MG

Packaging : Jul-28

Approval Date :

Application Number : 2273217

Regulatory Info : Prescription

Registration Country : Canada

Portfolio PDF

Product Web Link

Digital Content

Website

Corporate PDF

Contact us
to update this info

Privacy policy
Terms and conditions
Disclaimers
LOOKING FOR A SUPPLIER?